Cargando…
PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044167/ http://dx.doi.org/10.1186/1546-0096-11-S2-O14 |
_version_ | 1782319096566644736 |
---|---|
author | Burgos-Vargas, R Tse, S Horneff, G Pangan, AL Unnebrink, K Anderson, JK |
author_facet | Burgos-Vargas, R Tse, S Horneff, G Pangan, AL Unnebrink, K Anderson, JK |
author_sort | Burgos-Vargas, R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4044167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40441672014-06-17 PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis Burgos-Vargas, R Tse, S Horneff, G Pangan, AL Unnebrink, K Anderson, JK Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044167/ http://dx.doi.org/10.1186/1546-0096-11-S2-O14 Text en Copyright © 2013 Burgos-Vargas et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Burgos-Vargas, R Tse, S Horneff, G Pangan, AL Unnebrink, K Anderson, JK PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title | PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title_full | PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title_fullStr | PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title_full_unstemmed | PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title_short | PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
title_sort | pres-final-2179: efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044167/ http://dx.doi.org/10.1186/1546-0096-11-S2-O14 |
work_keys_str_mv | AT burgosvargasr presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis AT tses presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis AT horneffg presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis AT panganal presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis AT unnebrinkk presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis AT andersonjk presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis |